HUMAN DNA VACCINES MARKET ANALYSIS
Global Human DNA Vaccines Market: Restraints
Increase in the unpredictability related to the stringent regulatory system for the approval of the product and less adoption of DNA vaccines in the developing countries are the major factors among others, which will hamper the market growth and will further challenge the growth of deoxyribonucleic acid (DNA) vaccines market in the forecast period. However, the biggest limitation in the development of DNA vaccines is their intrinsic low immunogenicity.
Moreover, the risk associated with the gene therapy acts as a restraint for the market growth. Gene therapy has some potential risks such as unwanted immune system reaction, an infection caused by a virus, and targeting the wrong cell which can adversely affect the growth of the market and thereby act as a restraint.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
